Quince Therapeutics, Inc. (QNCX)
About Quince Therapeutics, Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$84.0M
- Total assets
- $93.5M
- Market cap
- $19.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $58.1M
- Operating income
- -$58.1M
- Income tax
- $3.2M
- Net income
- -$80.8M
- EPS (basic)
- $-1.68
- EPS (diluted)
- $-1.68
Balance sheet
- Total assets
- $93.5M
- Current assets
- $22.9M
- Total liabilities
- $129.2M
- Current liabilities
- $43.2M
- Shareholders’ equity
- -$35.7M
Cash flow
- Operating cash flow
- -$41.4M
- Investing cash flow
- $23.2M
- Financing cash flow
- $17.9M
- Net cash flow
- -$403.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $19.8M
- EPS (diluted)
- $-1.68
- Shares outstanding
- 1.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 9, 2019
Quince Therapeutics, Inc. (QNCX) Stock Price
- Reported a net loss of $84.0M.
- Trading 98% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Quince Therapeutics, Inc..
Write a review
News about Quince Therapeutics, Inc.
News & sentiment via Polygon.io
Quince Therapeutics, Inc.: frequently asked questions
Is Quince Therapeutics, Inc. an American company?
Quince Therapeutics, Inc. is a US-based company headquartered in South San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Quince Therapeutics, Inc. headquartered?
Quince Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
Is Quince Therapeutics, Inc. publicly traded?
Yes — Quince Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol QNCX on the NASDAQ.
What does Quince Therapeutics, Inc. do?
Quince Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
